Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) is the global anti-antibiotic healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries. The company’s products are used to treat patients in surgical/advanced wound management, dermatology, women’s health and animal health; addressing the unmet medical needs of these markets. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. For more information, visit the company’s website at www.oculusis.com